103 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
-13424 of the American Recovery and Reinvestment Act of 2009), the Stark Law (42 U.S.C. § 1395nn), the exclusion laws (42 U.S.C. § 1320a-7), Social … Security Act § 1128 (42 U.S.C. § 1320a-7), Medicare (Title XVIII of the Social Security Act), and Medicaid (Title XIX of the Social Security Act
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
, sales, use, license, capital stock, transfer, franchise, registration, payroll, withholding, social security, unemployment, disability, value added
S-3ASR
EX-1.2
y6736us
30 Sep 22
Automatic shelf registration
4:17pm
425
yd9yxr49f14 z34t701
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
mlzrw5xfvcdwr0f
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
hiqofrya
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-99.1
8qhgtruu7avpd9x rza
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
o7f kpvgyva1jk
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
SC TO-T/A
grxvsvfn vj
30 Sep 20
Third party tender offer statement (amended)
8:06am
SC TO-T/A
5p8gnbhm7hjeir9dao0e
16 Sep 20
Third party tender offer statement (amended)
6:05am
SC TO-T/A
4fvj994ayd6xn8eno
11 Sep 20
Third party tender offer statement (amended)
6:07am
8-K
EX-10.2
hqq1fd7ui no9q
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm